Ameritas Investment Partners, Inc. I Teos Therapeutics, Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.86 Billion
- Q1 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 2,444 shares of ITOS stock, worth $35,291. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,444
Previous 2,444
-0.0%
Holding current value
$35,291
Previous $26,000
26.92%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ITOS
# of Institutions
142Shares Held
30.2MCall Options Held
84.6KPut Options Held
32.2K-
Black Rock Inc. New York, NY4.11MShares$59.4 Million0.0% of portfolio
-
Mpm Asset Management LLC Cambridge, MA2.74MShares$39.5 Million15.24% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2MShares$28.9 Million0.78% of portfolio
-
Boxer Capital, LLC San Diego, CA1.8MShares$26.1 Million1.28% of portfolio
-
Bio Impact Capital LLC Cambridge, MA1.75MShares$25.2 Million3.9% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $514M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...